Related Experiment Videos
Serum enzyme changes after endoscopic retrograde cholanigo-pancreatography/ERCP/
Acta Hepato-Gastroenterologica
|June 1, 1978
Summary
Endoscopic retrograde cholangiopancreatography (ERCP) significantly elevates amylase and lipase levels, indicating a high rate of subclinical pancreatitis. However, severe acute pancreatitis after ERCP is rare, though potential complications warrant careful patient selection.
Area of Science:
- Gastroenterology
- Biochemistry
- Medical Imaging
Background:
- Endoscopic retrograde cholangiopancreatography (ERCP) is a common procedure for diagnosing and treating biliary and pancreatic conditions.
- Post-ERCP complications, particularly pancreatitis, are a known concern.
- Enzyme level monitoring is crucial for assessing pancreatic injury.
Purpose of the Study:
- To investigate the impact of ERCP on a wide range of serum enzyme levels.
- To determine the incidence of subclinical and overt pancreatitis following ERCP.
- To evaluate the significance of enzyme changes in predicting ERCP-related complications.
Main Methods:
- Serum enzyme levels were measured in patients undergoing ERCP.
- Twelve different enzymes were analyzed, with a focus on amylase (AML) and lipase (LIP).
- Enzyme activity was monitored over a 40-hour period post-procedure.
Main Results:
- A highly significant increase in amylase and lipase levels was observed post-ERCP.
- Minor, transient increases were noted in 13 other enzymes, which did not persist.
- A high incidence of subclinical pancreatitis-like changes was detected, contrasting with a low rate of typical acute pancreatitis.
Conclusions:
- ERCP leads to significant, albeit often subclinical, pancreatic enzyme elevations.
- While overt acute pancreatitis is rare, the potential for post-ERCP complications necessitates careful patient selection.
- Monitoring amylase and lipase is important for evaluating ERCP outcomes.